Suppr超能文献

简化急性生理学评分II作为脓毒性休克患者接受体外膜肺氧合治疗死亡率的预测指标

The Simplified Acute Physiology Score II as a Predictor of Mortality in Patients Who Underwent Extracorporeal Membrane Oxygenation for Septic Shock.

作者信息

Choi Myung Jin, Ha Sang Ook, Kim Hyoung Soo, Park Sunghoon, Han Sang Jin, Lee Sun Hee

机构信息

Department of Internal Medicine, Chuncheon Sacred Heart Hospital, Hallym University Sacred Heart Hospital, Hallym University Medical Center, Chuncheon-si, Korea.

Department of Emergency Medicine, Hallym University Sacred Heart Hospital, Hallym University Medical Center, Anyang-si, Gyeonggi-do, Korea.

出版信息

Ann Thorac Surg. 2017 Apr;103(4):1246-1253. doi: 10.1016/j.athoracsur.2016.07.069. Epub 2016 Oct 13.

Abstract

BACKGROUND

The use of extracorporeal membrane oxygenation (ECMO) for patients with septic shock is controversial. The outcomes are favorable in children but heterogeneous in adults. The present study aimed to analyze the outcomes of adult patients who underwent ECMO for septic shock, and to determine the factors associated with prognosis.

METHODS

We respectively reviewed the medical records of patients who underwent ECMO for septic shock between January 2007 and December 2013. Patients were divided into survivor and nonsurvivor groups based on survival to hospital discharge. The patient characteristics before and during ECMO were compared between the groups. Independent risk factors for mortality were evaluated using multivariate logistic regression, receiver-operating characteristic curves, and Kaplan-Meier analysis.

RESULTS

Twenty-eight patients were treated with venoarterial (n = 21), venovenous (n = 4), or venoarteriovenous (n = 3) mode ECMO. The overall survival rate to hospital discharge was 35.7%. The Simplified Acute Physiology Score II (SAPS II) and prealbumin were predictors of survival to hospital discharge. The optimal cutoff value for SAPS II was 80 (area under the curve 0.80, p = 0.010). Kaplan-Meier survival curves showed that the cumulative survival rate at hospital discharge and at 54-month follow-up was significantly higher among patients with SAPS II of 80 or less compared with patients with SAPS II greater than 80 (66.7% versus 12.5% and 58.3% versus 12.5%, respectively; p = 0.001).

CONCLUSIONS

It is still difficult to conclude whether ECMO should be recommended as therapy for adult patients with septic shock. However, a SAPS II score of 80 or less may be an indicator of favorable outcomes with the use of ECMO.

摘要

背景

对于感染性休克患者使用体外膜肺氧合(ECMO)存在争议。在儿童中结果良好,但在成人中结果各异。本研究旨在分析接受ECMO治疗感染性休克的成年患者的结局,并确定与预后相关的因素。

方法

我们分别回顾了2007年1月至2013年12月期间接受ECMO治疗感染性休克的患者的病历。根据出院时的存活情况将患者分为存活组和非存活组。比较两组患者在ECMO治疗前及治疗期间的特征。使用多因素逻辑回归、受试者工作特征曲线和Kaplan-Meier分析评估死亡的独立危险因素。

结果

28例患者接受了静脉-动脉(n = 21)、静脉-静脉(n = 4)或静脉-动脉-静脉(n = 3)模式的ECMO治疗。出院时的总体存活率为35.7%。简化急性生理学评分II(SAPS II)和前白蛋白是出院存活的预测指标。SAPS II的最佳截断值为80(曲线下面积0.80,p = 0.010)。Kaplan-Meier生存曲线显示,与SAPS II大于80的患者相比,SAPS II为80或更低的患者出院时及54个月随访时的累积存活率显著更高(分别为66.7%对12.5%和58.3%对12.5%;p = 0.001)。

结论

对于是否应推荐将ECMO作为成年感染性休克患者治疗方法仍难以定论。然而,SAPS II评分80或更低可能是使用ECMO获得良好结局的一个指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验